Literature DB >> 24987318

Topical steroid therapy for eosinophilic esophagitis.

Jeffrey A Alexander1.   

Abstract

Entities:  

Year:  2014        PMID： 24987318      PMCID： PMC4076881     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

1.  Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis.

Authors:  Alex Straumann; Sebastien Conus; Lukas Degen; Cornelia Frei; Christian Bussmann; Christoph Beglinger; Alain Schoepfer; Hans-Uwe Simon
Journal:  Clin Gastroenterol Hepatol       Date:  2011-01-28       Impact factor: 11.382

2.  Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis.

Authors:  Jeffrey A Alexander; Kee Wook Jung; Amindra S Arora; Felicity Enders; David A Katzka; Gail M Kephardt; Hirohito Kita; Lori A Kryzer; Yvonne Romero; Thomas C Smyrk; Nicholas J Talley
Journal:  Clin Gastroenterol Hepatol       Date:  2012-04-01       Impact factor: 11.382

3.  Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner.

Authors:  Alain M Schoepfer; Ekaterina Safroneeva; Christian Bussmann; Tanja Kuchen; Susanne Portmann; Hans-Uwe Simon; Alex Straumann
Journal:  Gastroenterology       Date:  2013-08-13       Impact factor: 22.682

4.  Steroid treatment of eosinophilic esophagitis in adults.

Authors:  Jeffrey A Alexander
Journal:  Gastroenterol Clin North Am       Date:  2014-03-24       Impact factor: 3.806

5.  Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis.

Authors:  Evan S Dellon; Arif Sheikh; Olga Speck; Kimberly Woodward; Ann B Whitlow; Jessica M Hores; Marija Ivanovic; Allen Chau; John T Woosley; Ryan D Madanick; Roy C Orlando; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2012-05-03       Impact factor: 22.682
  5 in total
  5 in total

1.  Variability in Practices of Compounding Budesonide for Eosinophilic Esophagitis.

Authors:  Sagar Joshi; Joel H Rubenstein; Evan S Dellon; Nathan Worthing; Zoe Stefanadis; Joy W Chang
Journal:  Am J Gastroenterol       Date:  2021-06-01       Impact factor: 12.045

2.  Clinical Translation of Tethered Confocal Microscopy Capsule for Unsedated Diagnosis of Eosinophilic Esophagitis.

Authors:  Nima Tabatabaei; DongKyun Kang; Minkyu Kim; Tao Wu; Catriona N Grant; Mireille Rosenberg; Norman S Nishioka; Paul E Hesterberg; John Garber; Qian Yuan; Aubrey J Katz; Guillermo J Tearney
Journal:  Sci Rep       Date:  2018-02-08       Impact factor: 4.379

3.  Disease Burden and Treatment Patterns Associated With Eosinophilic Esophagitis in the United States: A Retrospective Claims Study.

Authors:  Mei Lu; Bridgett Goodwin; Montserrat Vera-Llonch; James Williams
Journal:  J Clin Gastroenterol       Date:  2022-02-01       Impact factor: 3.174

Review 4.  Allergy-Test-Based Elimination Diets for the Treatment of Eosinophilic Esophagitis: A Systematic Review of Their Efficacy.

Authors:  Constantinos Pitsios; Emilia Vassilopoulou; Katerina Pantavou; Ingrid Terreehorst; Anna Nowak-Wegzryn; Antonella Cianferoni; Georgios Panagiotis Tsigkrelis; Maria Papachristodoulou; Stefanos Bonovas; Georgios K Nikolopoulos
Journal:  J Clin Med       Date:  2022-09-24       Impact factor: 4.964

5.  Compounded Oral Viscous Budesonide is Effective and Provides a Durable Response in Eosinophilic Esophagitis.

Authors:  Craig C Reed; Claire Fan; Nathaniel Koutlas; Zoe Stefanadis; Swathi Eluri; Nicholas J Shaheen; Evan S Dellon
Journal:  HSOA J Gastroenterol Hepatol Res       Date:  2018-02-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.